Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Clinical trial NCT02250937 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02250937
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-27
- Primary completion
- 2027-10-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.